The Transcriptome of Balamuthia Mandrillaris Trophozoites for Structure-Based Drug 2 Design 3 Isabelle Q
bioRxiv preprint doi: https://doi.org/10.1101/2020.06.29.178905; this version posted June 30, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 The transcriptome of Balamuthia mandrillaris trophozoites for structure-based drug 2 design 3 Isabelle Q. Phan1,2*Δ, Christopher A. Rice3,†*Δ, Justin Craig1,4, Rooksana E. Noorai5, Jacquelyn 4 McDonald2, Sandhya Subramanian1,2, Logan Tillery1,4, Lynn K. Barrett1,4, Vijay Shankar6, James 5 C. Morris7, Wesley C. Van Voorhis1,4,8,9 Dennis E. Kyle3, Peter J. Myler1,2,9,10Δ 6 1Seattle Structural Genomics Center for Infectious Disease (SSGCID), Seattle, Washington, USA. 7 2Center for Global Infectious Disease Research, Seattle Children’s Research Institute, Seattle, 8 Washington, USA. 9 3Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia, USA. 10 4Center for Emerging and Re-emerging Infectious Diseases (CERID), Division of Allergy and 11 Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, 12 USA. 13 5Clemson University Genomics and Bioinformatics Facility, Clemson University, Clemson, South 14 Carolina, USA. 15 6Center for Human Genetics, Clemson University, Greenwood, South Carolina, USA. 16 7Eukaryotic Pathogens Innovation Center, Department of Genetics and Biochemistry, Clemson 17 University, Clemson, South Carolina, USA. 18 8Department of Microbiology, University of Washington, Seattle, Washington, USA. 19 9Department of Global Health, University of Washington, Seattle, Washington, USA. 20 10Department of Pediatrics, University of Washington, Seattle, Washington, USA.
[Show full text]